When Bill Frankland began practising in the 1940s, allergy medicine was barely a discipline. The allergist Adam Fox said: To say Bill Frankland was the grandfather of allergy medicine doesnt do it justice. He wasnt the grandfather in the sense of being the oldest but in the sense of being the originator of the speciality. He did the original trials and founded the British society. He was still practising in his 90s and 100s, and remained the doctor people wanted to see.
On his release from a Japanese prisoner of war camp in 1945, Frankland, who has died aged 108, returned to St Marys hospital, Paddington, in London, where he had trained. He had suffered with hay fever since he was nine, and when he saw an advertisement for a part-time assistant in the allergy department, he applied. In February 1946 he became full-time and for the next 70 years was gripped by allergy medicine, which he said was like a fascinating detective story.
Frankland worked at the allergy clinic at St Marys hospital for more than 30 years, and was its director from 1958 until he retired in 1977. A few years later it was renamed the Frankland Allergy Clinic. It was the busiest in the country, and it is estimated that Frankland oversaw the desensitisation treatment of around 30,000 hay fever patients. At the same time, he also ran the hospitals pollen farm near Woking, Surrey, until it closed in 1970.
In 1948 the British Association of Allergists was formed with 30 members and Frankland as its secretary. It grew rapidly as it widened its scope to include immunology, becoming the British Society for Allergy and Clinical Immunology (BSACI) in 1973. Frankland was its president from 1963 to 1966 and remained at its heart all his life.
When he began his career in the late 1940s antihistamines had recently come on stream to treat allergies. Frankland was involved in several trials, demonstrating that two antihistamines reduced hay fever symptoms but were not effective for asthma.
Allergen desensitisation for hay fever had been used since 1911, but had not been properly evaluated. Frankland had read about double-blind placebo-controlled trials and wanted to apply them to his discipline. Patients at that time were injected with a grass-pollen extract called Pollaccine to desensitise them.
Frankland was concerned that it contained material that gave unwanted side-effects and wanted to determine exactly which part of the pollen extract was effective. In 1953 he recruited 200 hay fever patients and showed that a purified pollen protein worked just as well as Pollaccine. His paper, published in 1954, was a milestone: the first double-blind randomised clinical trial in immunotherapy; 65 years later, Frankland was gratified to see it celebrated on the 2018 cover of the journal Allergy.
In the 40s and 50s it was difficult for hay fever patients to control their symptoms without information on what type of pollen and how much of it was in the air. Frankland knew that atmospheric levels of pollen were being measured in Cardiff and wanted to do the same in London. In 1953 he installed a Hirst spore trap on the roof of the nurses home at St Marys and recruited a biologist (whose name he was amused to recount was Miss Hay) to provide daily pollen counts and analyse the prevalence of different pollens. Initially the information went out once a week to members of the British Association of Allergists, but, to disseminate it further, in 1963 Frankland persuaded the Times and the Daily Telegraph to print a daily pollen count. (It is now part of the weather forecast and coordinated by the Met Office.)
As well as his other duties at St Marys, in the 40s Frankland spent two years as Sir Alexander Flemings clinical assistant. He took care of Flemings patients, reporting on their progress every morning at 10am even though Fleming preferred to discuss other subjects.
Frankland said: He just wasnt interested in clinical medicine once he looked down a microscope, he continued looking down a microscope
In 1948 the publisher Butterworths asked for a new chapter on sensitivities in Flemings bestseller Penicillin: Its Practical Application, and Fleming tasked Frankland with writing it. Fleming himself did not accept that people could be allergic to penicillin, saying adverse reactions must be the result of drug impurities. When he read Franklands draft, he crossed out the last sentence: With the increasing use of penicillin, it is to be expected that allergic reactions will become more common, substituting: With the increasing use of penicillin, reactions due to impurities will become less common. Frankland disagreed, but did not feel he should argue with the Nobel prize winner.
In his long career Frankland treated many patients including, in 1979, Saddam Hussein, whose symptoms were caused by cigarettes rather than asthma. He told him: If youre not eating, sleeping or praying, youre smoking. If you carry on, you wont be president in two years time. Saddam heeded the advice and later flew Frankland out to Baghdad for a celebratory lunch.
As well as asthma and hay fever, Frankland was interested in many different allergies, and, in the now no longer permissible tradition of self-experimentation, in 1955 allowed the South American insect Rhodnius prolixus to bite him weekly so he could observe the reaction. He got the insect from the London School of Hygiene and Tropical Medicine and kept it in the glove compartment of his car. After eight weeks, he had a severe anaphylactic reaction and was saved by two injections of adrenaline. Three hours later, he helped a nurse push her car. The strenuous exercise brought on anaphylaxis again, requiring a third shot of adrenaline. This experience led to his interest in the delay that is possible in allergic reactions.
Frankland was born near Bexhill-on-Sea, East Sussex. His father, Henry, was a vicar and his mother, Rose (nee West), a musician. He was an identical twin and nearly didnt survive because he was born prematurely and was tiny, weighing just over 3lb (1.4kg). The family moved to Cumberland (now Cumbria), in north-west England, and Frankland remembered getting postcards from his father who was away during the first world war.
When he was nine he caught tuberculosis, and was unimpressed with the doctor treating him, deciding he could do a better job and should study medicine. He went to St Bees school in the county and then to Queens College, Oxford, to study natural sciences. His studies were interrupted for six months when he returned home to care for his elder sister Ella, who had scarlet fever. She died in October 1933 and he returned to Oxford before moving to St Marys hospital, qualifying as a doctor in 1938.
Two days before the second world war was declared in September 1939, Frankland volunteered as a civilian medical practitioner in the army. He was shipped out to Singapore, where his life was saved a second time. Another doctor and I decided to spin a coin to determine our assignments, he said. I called heads and won. The man who lost went to [the] Alexandra hospital where he was brutally murdered by Japanese forces in 1942.
Frankland, however, was captured and became a Japanese PoW. In 1943 he was moved to Pulau Blakang Mati (now Sentosa Island), off Singapores southern coast, where his two days of tropical medicine training were scant preparation for the array of malnutrition, malaria, dengue and beri-beri he faced. He was nearly bayoneted to death during a punishment bashing from Japanese soldiers, and his life was saved yet again when the Americans dropped atomic bombs on Hiroshima and Nagasaki in 1945, ending the war and preventing mass shooting of PoWs.
Frankland returned home in October of that year. He had married Pauline Jackson, an optometrist, in 1941, and had treasured her letters. When he arrived in Liverpool, he was asked if he wanted to see a psychiatrist and replied: No. I want to see my wife.
Frankland decided not to talk about his experiences to Pauline or to his family. He said: When I got back, I thought Im alive and this is marvellous. Im going to forget everything Ive gone through. When he was nearly 100, he told a colleague he watched a TV programme about VE Day and had his first flashback. Thereafter he was amenable to talking about his experiences.
When Frankland left St Marys in 1977, he became an honorary consultant at Guys hospital in London, where he saw patients into his 90s. He also worked as an expert witness in court cases, and continued to write papers and attend conferences. Each year he presented the BSACI William Frankland award. He had a wide circle of friends and a great zest for life, remembered by one colleague as enjoying tea at the Ritz and riding a dodgem car aged 103.
Pauline died in 2002, and two years ago Frankland moved from his flat in Marylebone to accommodation in the Charterhouse, central London. When asked about his life, Frankland said: I have been very lucky.
He is survived by two sons and two daughters, 10 grandchildren and six great-grandchildren.
Alfred William Frankland, immunologist, born 19 March 1912; died 2 April 2020
Read the original post:
William Frankland obituary - The Guardian
- Department of Microbiology and Immunology Named a National Milestones Program - Stony Brook News - October 26th, 2024 [October 26th, 2024]
- Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting - businesswire.com - October 26th, 2024 [October 26th, 2024]
- Remembering immunology educator, researcher Tom McDonald, PhD - University of Nebraska Medical Center - October 13th, 2024 [October 13th, 2024]
- Systems immunology approaches to study T cells in health and disease - Nature.com - October 13th, 2024 [October 13th, 2024]
- Leading the charge to discover answers in immunology - The University of Arizona - October 2nd, 2024 [October 2nd, 2024]
- New mouse models offer valuable window into COVID-19 infection - La Jolla Institute for Immunology - October 2nd, 2024 [October 2nd, 2024]
- Wide-Moat AbbVie Poised for Growth, Driven by Innovation in Immunology Beyond Humira - Morningstar - October 2nd, 2024 [October 2nd, 2024]
- Lilly's immunology unit scores another FDA nod with eczema treatment Ebglyss - FiercePharma - September 23rd, 2024 [September 23rd, 2024]
- Huang Named Head Of Pathology And Immunology - Mirage News - September 15th, 2024 [September 15th, 2024]
- Huang named head of pathology & immunology - Washington University School of Medicine in St. Louis - September 15th, 2024 [September 15th, 2024]
- Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit - Yahoo Finance - September 15th, 2024 [September 15th, 2024]
- Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit - StockTitan - September 15th, 2024 [September 15th, 2024]
- UCLA receives $120 million from Alya and Gary Michelson for new California Institute for Immunology and Immunotherapy - UCLA Newsroom - September 2nd, 2024 [September 2nd, 2024]
- Boosting vaccines for the elderly with 'hyperactivators' - Boston Children's Answers - Boston Children's Discoveries - June 27th, 2024 [June 27th, 2024]
- Immunologists Want You to Know These Dust Mite Allergy Facts - Yahoo Lifestyle UK - June 27th, 2024 [June 27th, 2024]
- How Ragon Institute's new building aids its mission Harvard Gazette - Harvard Gazette - June 27th, 2024 [June 27th, 2024]
- Insights into CRS and NPs: Visual and Bibliometric Analysis - Physician's Weekly - June 27th, 2024 [June 27th, 2024]
- Biogen joins immunology wave with $1.15 billion acquisition of HI-Bio - STAT - May 24th, 2024 [May 24th, 2024]
- Biogen Buys Desired Growth In Immunology With $1.15bn Hi-Bio Deal - Scrip - May 24th, 2024 [May 24th, 2024]
- Biogen Boosts Immunology Portfolio with $1.8 Billion Acquisition of HI-Bio - BioPharm International - May 24th, 2024 [May 24th, 2024]
- Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395 - Yahoo Finance - May 24th, 2024 [May 24th, 2024]
- Biogen to expand immunology and rare disease portfolio with $1.8bn HI-Bio acquisition - PMLiVE - May 24th, 2024 [May 24th, 2024]
- Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress - Business Wire - May 24th, 2024 [May 24th, 2024]
- Biogen to buy Human Immunology Biosciences in deal worth up to $1.8B - MM+M Online - May 24th, 2024 [May 24th, 2024]
- COVID-19 Re-Vaccinations Elicit Neutralizing Antibodies Against Future Variants - Technology Networks - May 24th, 2024 [May 24th, 2024]
- HIV Vaccine Candidate Induces Broadly Neutralizing Antibodies in Humans - Technology Networks - May 24th, 2024 [May 24th, 2024]
- Pasteur Fiocruz Center on Immunology and Immunotherapy is inaugurated in Cear - Fiocruz - May 24th, 2024 [May 24th, 2024]
- Biogen to buy Human Immunology Biosciences in up to $1.8 billion deal - Marketscreener.com - May 24th, 2024 [May 24th, 2024]
- Fellow Focus in Four: Marat Kribis, MD, Rheumatology, Allergy and Immunology - Yale School of Medicine - April 15th, 2024 [April 15th, 2024]
- Long COVID Can Now Be Detected in the Blood - Technology Networks - April 15th, 2024 [April 15th, 2024]
- Rimjhim Agarwal selected as Major Symposium speaker at the American Association of Immunologists ... - La Jolla Institute for Immunology - March 29th, 2024 [March 29th, 2024]
- Seeking new horizons: Where innovators find opportunities in a fast-changing immunology landscape - IQVIA - March 29th, 2024 [March 29th, 2024]
- Researchers identify new way to inhibit immune cells that drive allergic asthma - EurekAlert - March 29th, 2024 [March 29th, 2024]
- Innovation in Oncology and Cancer Immunology Research - Boehringer Ingelheim - March 29th, 2024 [March 29th, 2024]
- Measles outbreaks show the risk of under-vaccination | News | Harvard T.H. Chan School of Public Health - HSPH News - March 29th, 2024 [March 29th, 2024]
- Immunology-oncology ELISA Kits Market to Witness a Healthy Growth by 2030 - WhaTech - March 29th, 2024 [March 29th, 2024]
- Spring Allergy Season Is Getting Worse. Here's What to Know. - The New York Times - March 29th, 2024 [March 29th, 2024]
- Multiple sclerosis has distinct subtypes, study finds, pointing to different treatments - STAT - March 29th, 2024 [March 29th, 2024]
- Researchers identify viable vaccine targets for hepatitis C infections - News-Medical.Net - March 29th, 2024 [March 29th, 2024]
- Three research projects awarded funding from the Immunology Institute Pilot Project program - University of Alabama at Birmingham - February 29th, 2024 [February 29th, 2024]
- Deal Watch: AbbVie Adds To Immunology Pipeline Through Deal With OSE - Scrip - February 29th, 2024 [February 29th, 2024]
- AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific Biologics for Oncology ... - PR Newswire - February 29th, 2024 [February 29th, 2024]
- Integrating single-cell multi-omics and prior biological knowledge for a functional characterization of the immune system - Nature.com - February 29th, 2024 [February 29th, 2024]
- Renowned immunologist and four-decade UAB researcher Max Cooper, M.D., will deliver this year's Marx Lecture - University of Alabama at Birmingham - February 29th, 2024 [February 29th, 2024]
- Inactivation of TGF- signaling in CAR-T cells | Cellular & Molecular Immunology - Nature.com - February 29th, 2024 [February 29th, 2024]
- Babies use their immune system differently but efficiently | Cornell Chronicle - Cornell Chronicle - February 29th, 2024 [February 29th, 2024]
- Antibody reduces allergic reactions to multiple foods in NIH clinical trial - National Institutes of Health (NIH) (.gov) - February 29th, 2024 [February 29th, 2024]
- Mestag Therapeutics Enlists Leading Cancer Biology and Immunology Advisors to Support Clinical Development of its ... - GlobeNewswire - February 21st, 2024 [February 21st, 2024]
- Theratechnologies announces publication in Frontiers in Immunology on TH1902 - TipRanks.com - TipRanks - February 21st, 2024 [February 21st, 2024]
- Smoking has long-term effects on the immune system - Institut Pasteur - February 21st, 2024 [February 21st, 2024]
- Spring Allergies Attack More Than Just Your Nose - ACAAI Public Website - American College of Allergy Asthma and Immunology - February 21st, 2024 [February 21st, 2024]
- Theratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel ... - GlobeNewswire - February 21st, 2024 [February 21st, 2024]
- Shikhar Mehrotra named co-leader of Cancer Biology and Immunology research program at MUSC Hollings - The Cancer Letter - January 27th, 2024 [January 27th, 2024]
- Gut Microbiome Benefits of Breast Milk Revealed in Mouse Study - Technology Networks - January 27th, 2024 [January 27th, 2024]
- Research on Immunological Diseases Launches with Hungarian Participation - Hungary Today - January 27th, 2024 [January 27th, 2024]
- UCLA to turn former shopping mall into centers for research on immunology and quantum science - The Associated Press - January 8th, 2024 [January 8th, 2024]
- TRexBio Announces a First Option Was Exercised by Partner under Immunology Discovery Collaboration - Business Wire - January 8th, 2024 [January 8th, 2024]
- UCLA to turn former Westside Pavilion into centers for research on immunology and quantum science - KABC-TV - January 8th, 2024 [January 8th, 2024]
- HI-Bio Announces $95 Million Series B Financing to Advance Targeted Therapies for Immune-Mediated Diseases - PR Newswire - January 8th, 2024 [January 8th, 2024]
- Beyond Cytotoxicity: The Importance of T Cell Memory - The Scientist - January 8th, 2024 [January 8th, 2024]
- IKAROS: Unlocking the secrets of the immune system's key player - News-Medical.Net - January 8th, 2024 [January 8th, 2024]
- UCLA to turn former shopping mall into centers for research on immunology and quantum science - The Caledonian-Record - January 8th, 2024 [January 8th, 2024]
- Revolutionizing Vaccine Research: The Power of a New Algorithm - SciTechDaily - December 31st, 2023 [December 31st, 2023]
- Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people ... - Nature.com - December 22nd, 2023 [December 22nd, 2023]
- Two new practice parameters offer recommendations for treating anaphylaxis and atopic dermatitis - News-Medical.Net - December 22nd, 2023 [December 22nd, 2023]
- Physician and Patient (Un)Wellness in Allergy and Immunology During COVID-19 and Beyond: Lessons for the Future - Physician's Weekly - December 22nd, 2023 [December 22nd, 2023]
- Researchers Identify Why Some Cancers Do Not Respond to Immunotherapy - NYU Langone Health - December 22nd, 2023 [December 22nd, 2023]
- MU's Haval Shirwan recognized for achievements in immunology - Columbia Daily Tribune - December 22nd, 2023 [December 22nd, 2023]
- Parker Institute for Cancer Immunotherapy (PICI) Welcomes Weill Cornell Medicine to Cancer Research Consortium - Weill Cornell Medicine Newsroom - December 14th, 2023 [December 14th, 2023]
- Annals of Allergy, Asthma and Immunology Examines Effects of Climate Change on Allergic Conditions - Newswise - December 14th, 2023 [December 14th, 2023]
- British Society for Immunology response to the NHS vaccination strategy - British Society for Immunology | - December 14th, 2023 [December 14th, 2023]
- NYU Langone Health in the NewsFriday, December 8, 2023 - NYU Langone Health - December 14th, 2023 [December 14th, 2023]
- Arturo Casadevall Named Distinguished Fellow by the American Association of Immunologists - Johns Hopkins Bloomberg School of Public Health - December 14th, 2023 [December 14th, 2023]
- ImmunoScape Appoints Systems Immunology and Computational Biology Expert Dr. John Tsang to its Scien - PharmiWeb.com - December 14th, 2023 [December 14th, 2023]
- Ishares Genomics Immunology And Healthcare Etf ($IDNA) Proactive Strategies - Stock Traders Daily - December 14th, 2023 [December 14th, 2023]
- Medical Breakthroughs Fueling Infection Prevention Market: Immunology and Modern Medicine Advancements to ... - PR Newswire - December 14th, 2023 [December 14th, 2023]
- Cancer therapy bexmarilimab awakens immune cells to attack tumors that have avoided the detection of the immune ... - EurekAlert - December 14th, 2023 [December 14th, 2023]
- Testing Cancer Immunotherapies on Mice with Human Immune Systems - Mirage News - December 14th, 2023 [December 14th, 2023]
- Georgetown School of Medicine's Department of Immunology Hosts Talk About Therapeutic Vaccine for Autoimmune ... - Georgetown University The Hoya - December 6th, 2023 [December 6th, 2023]
- Long COVID Research Is a Bit of a Mess - Technology Networks - December 6th, 2023 [December 6th, 2023]